Breaking News Instant updates and real-time market news.

OMEX

Odyssey Marine

$7.03 /

+0.02 (+0.29%)

08:36
09/16/20
09/16
08:36
09/16/20
08:36

Odyssey Marine files First Memorial in Mexico NAFTA case

Odyssey Marine Exploration reports that on Friday, September 4, 2020, Odyssey filed the First Memorial in the case brought against Mexico under the North American Free Trade Agreement on its behalf and on behalf of subsidiary Exploraciones Oceanicas, alleging that Mexico wrongfully denied environmental approval of the ExO Phosphate project in breach of NAFTA. The First Memorial presents Odyssey's NAFTA claims that Mexico, among other things: Violated the Minimum Standard of Treatment; Indirectly expropriated the investment; and Treated the investment less favorably than it treated domestic investors.Odyssey seeks damages of more than $2.3 billion including interest from April 2016 to the date of the First Memorial's submission. The First Memorial is supported by documentary evidence, and 20 expert reports and witness statements. In summary, this evidence includes: MERITS: Testimony from independent environmental experts and legal experts that the environmental impact of ExO's phosphate project is minimal and readily mitigated by the mitigation measures proposed by ExO. Witnesses also testified that Mexico's denial of environmental approval by the prior administration was politically motivated and not justified on environmental grounds, and that Mexico granted environmental permits to similar dredging projects in areas that are considered more environmentally sensitive than ExO's project location. RESOURCE: An independent marine geologist testified as to the size and character of the resource. OPERATIONAL VIABILITY: Engineering experts testified that the project uses established dredging and processing technology, and the project's anticipated CAPEX and OPEX was reasonable. VALUE: A Phosphate market analyst testified that the project's projected CAPEX and OPEX would make the project one of the lowest cost phosphate rock resources in the world, and damages experts testified the project would be commercially viable and profitable.

TODAY'S FREE FLY STORIES

General news
Asian Market Update: » 03:05
10/25/21
10/25
03:05
10/25/21
03:05
$ECON

Economic Data

/

+

Asian Market Update: The…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
U.S. Dallas Fed preview » 03:05
10/25/21
10/25
03:05
10/25/21
03:05
$ECON

Economic Data

/

+

U.S. Dallas Fed preview:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Conference/Events
Accuray to hold analyst & investor meeting » 00:00
10/25/21
10/25
00:00
10/25/21
00:00
ARAY

Accuray

$4.37 /

+0.3 (+7.37%)

Analyst & Investor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARAY Accuray
$4.37 /

+0.3 (+7.37%)

ARAY Accuray
$4.37 /

+0.3 (+7.37%)

01/07/21
Fly Intel: Top five analyst initiations
01/07/21 Northland
Accuray initiated with an Outperform at Northland
ARAY Accuray
$4.37 /

+0.3 (+7.37%)

Upgrade
Simply Good Foods upgraded to Buy from Hold at Stifel » 21:40
10/24/21
10/24
21:40
10/24/21
21:40
SMPL

Simply Good Foods

$37.28 /

+3.01 (+8.78%)

Stifel analyst…

Stifel analyst Christopher Growe upgraded Simply Good Foods to Buy from Hold with a $42 price target.

ShowHide Related Items >><<
SMPL Simply Good Foods
$37.28 /

+3.01 (+8.78%)

SMPL Simply Good Foods
$37.28 /

+3.01 (+8.78%)

07/06/21 Stephens
Simply Good Foods assumed with an Equal Weight at Stephens
07/02/21 Deutsche Bank
Simply Good Foods price target raised to $43 from $38 at Deutsche Bank
07/02/21 Citi
Simply Good Foods price target raised to $43 from $40 at Citi
07/02/21 Goldman Sachs
Simply Good Foods price target raised to $42 from $36 at Goldman Sachs
SMPL Simply Good Foods
$37.28 /

+3.01 (+8.78%)

SMPL Simply Good Foods
$37.28 /

+3.01 (+8.78%)

Downgrade
N Brown Group downgraded to Hold from Buy at Jefferies » 20:53
10/24/21
10/24
20:53
10/24/21
20:53
NBRNF

N Brown Group

/

+

Jefferies analyst Andrew…

Jefferies analyst Andrew Wade downgraded N Brown Group to Hold from Buy with a price target of 50 GBp, down from 95 GBp. The company's first half results were "not as solid as it first appeared," as the company's EBITDA was boosted by a material financial services one-off, Wade tells investors in a research note. N Brown posted slowing product revenue trends and further declines in product gross margin, says the analyst.

Hot Stocks
Fly Intel: Top five weekend stock stories » 20:04
10/24/21
10/24
20:04
10/24/21
20:04
SBSW

Sibanye Stillwater

$14.46 /

+0.065 (+0.45%)

, FB

Facebook

$324.68 /

-17.41 (-5.09%)

, INTC

Intel

$49.46 /

-6.555 (-11.70%)

, AAPL

Apple

$148.69 /

-0.76 (-0.51%)

, DELL

Dell Technologies

$114.57 /

+1.56 (+1.38%)

, HPQ

HP Inc.

$30.48 /

-0.1 (-0.33%)

, T

AT&T

$25.48 /

-0.27 (-1.05%)

, CHK

Chesapeake

$62.06 /

+0.56 (+0.91%)

, IFNNY

Infineon

$44.99 /

+0.71 (+1.60%)

Catch up on the…

Catch up on the weekend's top five stories with this list compiled by The Fly: 1. Sibanye-Stillwater (SBSW) is in advanced talks to buy two Brazilian miners for about $1 billion including debt, a bet on continued demand for metals used in the production of electric-car batteries, The Wall Street Journal's Ben Dummett and Joe Wallace reported, citing people familiar with the matter. The miner would acquire Atlantic Nickel, which operates the Santa Rita mine, one of the world's biggest open-pit nickel sulfide mines, and Mineracao Vale Verde, which is developing a copper-and-gold mine, the people said. 2. According to researchers, Facebook's (FB) products in India were awash with inflammatory content that one report linked to deadly religious riots, The Wall Street Journal's Newley Purnell and Jeff Horwitz reported. Inflammatory content on Facebook spiked 300% above previous levels at times during the months following December 2019, a period in which religious protests swept India, researchers wrote in a July 2020 report that was reviewed by The Wall Street Journal. Rumors and calls to violence spread particularly on Facebook's WhatsApp messaging service in late February 2020, when communal violence in Delhi left 53 dead, according to the report. India is Facebook's biggest market with hundreds of millions of users. 3. Intel (INTC) fell nearly 10% Friday after the microprocessor company forecast disappointing earnings for its fourth quarter, Eric Savitz wrote in this week's edition of Barron's. Intel's woes come at a delicate moment for the PC sector, which saw a remarkable surge in demand during the pandemic, the author noted. Apple (AAPL), Dell Technologies (DELL) and HP Inc. (HPQ) all saw a spike in laptop sales over the past 18 months, as people shifted to working and learning from home. Many investors doubt that the boom can last, a view seemingly validated by Intel's forecast, but HP suggests otherwise, the publication adds. Once primarily driven by its printer ink and toner business, it's showing an "impressive surge" in innovation, Savitz contended. Thursday, HP held its first analyst meeting in two years, and had surprisingly good news that drove the stock up 7%, the publication pointed out. With an improving growth story, shareholder-friendly policies, and one of the cheapest stocks in the tech sector, HP looks like "a screaming buy," the author argued. 4. AT&T (T) subsidiary Warner Bros.' "Dune" won the domestic box office with a strong $40.1M debut despite its dual release as it opened simultaneously in 4,125 theaters across North America and on streamer HBO Max. Globally, the movie moved past the $100M mark after opening previously in earlier markets. "Dune" grossed another $47.4M from 75 markets overseas for a foreign cume of $180.6M and $220.2M globally. 5. Chesapeake (CHK) and Infineon (IFNNY) saw positive mentions in this week's edition of Barron's.

ShowHide Related Items >><<
T AT&T
$25.48 /

-0.27 (-1.05%)

SBSW Sibanye Stillwater
$14.46 /

+0.065 (+0.45%)

INTC Intel
$49.46 /

-6.555 (-11.70%)

IFNNY Infineon
$44.99 /

+0.71 (+1.60%)

HPQ HP Inc.
$30.48 /

-0.1 (-0.33%)

FB Facebook
$324.68 /

-17.41 (-5.09%)

DELL Dell Technologies
$114.57 /

+1.56 (+1.38%)

CHK Chesapeake
$62.06 /

+0.56 (+0.91%)

AAPL Apple
$148.69 /

-0.76 (-0.51%)

SBSW Sibanye Stillwater
$14.46 /

+0.065 (+0.45%)

10/12/21 Deutsche Bank
Sibanye Stillwater initiated with a Buy at Deutsche Bank
02/16/21 RBC Capital
Sibanye Stillwater price target raised to $28 from $25 at RBC Capital
11/27/20 Citi
Sibanye Stillwater initiated with a Buy at Citi
11/11/20 BMO Capital
Sibanye Stillwater initiated with an Outperform at BMO Capital
FB Facebook
$324.68 /

-17.41 (-5.09%)

10/22/21 Piper Sandler
Snap results raise uncertainty for digital advertising, says Piper Sandler
10/18/21 Wedbush
Wedbush continues to favor Google, Snap headed into quarterly results
10/18/21 Credit Suisse
Facebook algorithm, service outages grab investor attention, says Credit Suisse
10/15/21 Evercore ISI
Facebook added to 'Tactical Underperform List' at Evercore ISI
INTC Intel
$49.46 /

-6.555 (-11.70%)

10/22/21
Fly Intel: Top five analyst downgrades
10/22/21 BMO Capital
Intel price target lowered to $60 from $70 at BMO Capital
10/22/21 Citi
Intel price target lowered to $52 from $57 at Citi
10/22/21 Roth Capital
Intel price target lowered to $53 from $60 at Roth Capital
AAPL Apple
$148.69 /

-0.76 (-0.51%)

10/24/21 Credit Suisse
Apple iPhone waits remain extended amid supply constraints, says Credit Suisse
10/22/21 Truist
Snap price target lowered to $75 from $100 at Truist
10/22/21 Jefferies
Snap price target lowered to $76 from $90 at Jefferies
10/19/21 JPMorgan
JPMorgan sees Q4 beat for Apple with 'deja-vu' guidance for Q1
DELL Dell Technologies
$114.57 /

+1.56 (+1.38%)

09/24/21 Morgan Stanley
Dell Technologies price target lowered to $126 from $133 at Morgan Stanley
09/24/21 Citi
Dell trading at 20%-25% discount to peers, says Citi
09/17/21 Citi
Dell Technologies resumed with a Buy at Citi
09/17/21 Morgan Stanley
Morgan Stanley would be buyers of Dell Technologies ahead of analyst day
HPQ HP Inc.
$30.48 /

-0.1 (-0.33%)

09/29/21
Fly Intel: Top five analyst downgrades
09/29/21 JPMorgan
HP Inc. downgraded to Neutral from Overweight at JPMorgan
08/27/21
Fly Intel: Top five analyst downgrades
08/27/21 Morgan Stanley
Morgan Stanley prefers Dell to HP, ups price target to $133
T AT&T
$25.48 /

-0.27 (-1.05%)

10/19/21 Citi
AT&T price target lowered to $30 from $32 at Citi
10/14/21
Fly Intel: Top five analyst upgrades
10/14/21 KeyBanc
AT&T upgraded to Sector Weight from Underweight at KeyBanc
10/14/21 KeyBanc
AT&T upgraded to Sector Weight from Underweight at KeyBanc
CHK Chesapeake
$62.06 /

+0.56 (+0.91%)

10/07/21
Fly Intel: Top five analyst initiations
10/07/21 UBS
Chesapeake initiated with a Buy at UBS
08/27/21
Fly Intel: Top five analyst initiations
08/27/21 BMO Capital
Chesapeake reinstated with an Outperform at BMO Capital
IFNNY Infineon
$44.99 /

+0.71 (+1.60%)

10/06/21 Deutsche Bank
Infineon price target raised to EUR 43 from EUR 42 at Deutsche Bank
10/06/21 Barclays
Infineon price target raised to EUR 43 from EUR 41 at Barclays
09/23/21 UBS
Infineon price target raised to EUR 45 from EUR 43 at UBS
08/30/21 Stifel
Infineon upgraded to Buy from Hold at Stifel
T AT&T
$25.48 /

-0.27 (-1.05%)

INTC Intel
$49.46 /

-6.555 (-11.70%)

HPQ HP Inc.
$30.48 /

-0.1 (-0.33%)

FB Facebook
$324.68 /

-17.41 (-5.09%)

DELL Dell Technologies
$114.57 /

+1.56 (+1.38%)

CHK Chesapeake
$62.06 /

+0.56 (+0.91%)

AAPL Apple
$148.69 /

-0.76 (-0.51%)

T AT&T
$25.48 /

-0.27 (-1.05%)

SBSW Sibanye Stillwater
$14.46 /

+0.065 (+0.45%)

INTC Intel
$49.46 /

-6.555 (-11.70%)

IFNNY Infineon
$44.99 /

+0.71 (+1.60%)

FB Facebook
$324.68 /

-17.41 (-5.09%)

DELL Dell Technologies
$114.57 /

+1.56 (+1.38%)

CHK Chesapeake
$62.06 /

+0.56 (+0.91%)

AAPL Apple
$148.69 /

-0.76 (-0.51%)

T AT&T
$25.48 /

-0.27 (-1.05%)

INTC Intel
$49.46 /

-6.555 (-11.70%)

HPQ HP Inc.
$30.48 /

-0.1 (-0.33%)

FB Facebook
$324.68 /

-17.41 (-5.09%)

DELL Dell Technologies
$114.57 /

+1.56 (+1.38%)

CHK Chesapeake
$62.06 /

+0.56 (+0.91%)

AAPL Apple
$148.69 /

-0.76 (-0.51%)

T AT&T
$25.48 /

-0.27 (-1.05%)

SBSW Sibanye Stillwater
$14.46 /

+0.065 (+0.45%)

INTC Intel
$49.46 /

-6.555 (-11.70%)

HPQ HP Inc.
$30.48 /

-0.1 (-0.33%)

FB Facebook
$324.68 /

-17.41 (-5.09%)

DELL Dell Technologies
$114.57 /

+1.56 (+1.38%)

AAPL Apple
$148.69 /

-0.76 (-0.51%)

AAPL Apple
$148.69 /

-0.76 (-0.51%)

Periodicals
Sibanye-Stillwater nears $1B deal to buy two Brazilian miners, WSJ reports » 19:57
10/24/21
10/24
19:57
10/24/21
19:57
SBSW

Sibanye Stillwater

$14.46 /

+0.065 (+0.45%)

Sibanye-Stillwater (SBSW)…

Sibanye-Stillwater (SBSW) is in advanced talks to buy two Brazilian miners for about $1 billion including debt, a bet on continued demand for metals used in the production of electric-car batteries, The Wall Street Journal's Ben Dummett and Joe Wallace report, citing people familiar with the matter. The miner would acquire Atlantic Nickel, which operates the Santa Rita mine, one of the world's biggest open-pit nickel sulfide mines, and Mineracao Vale Verde, which is developing a copper-and-gold mine, the people said. Reference Link

ShowHide Related Items >><<
SBSW Sibanye Stillwater
$14.46 /

+0.065 (+0.45%)

SBSW Sibanye Stillwater
$14.46 /

+0.065 (+0.45%)

10/12/21 Deutsche Bank
Sibanye Stillwater initiated with a Buy at Deutsche Bank
02/16/21 RBC Capital
Sibanye Stillwater price target raised to $28 from $25 at RBC Capital
11/27/20 Citi
Sibanye Stillwater initiated with a Buy at Citi
11/11/20 BMO Capital
Sibanye Stillwater initiated with an Outperform at BMO Capital
SBSW Sibanye Stillwater
$14.46 /

+0.065 (+0.45%)

Recommendations
RLI Corp. price target raised to $125 from $120 at Keefe Bruyette » 19:24
10/24/21
10/24
19:24
10/24/21
19:24
RLI

RLI Corp.

$108.21 /

+0.615 (+0.57%)

Keefe Bruyette analyst…

Keefe Bruyette analyst Meyer Shields raised the firm's price target on RLI Corp. to $125 from $120 and keeps an Outperform rating on the shares following the "solid" Q3 earnings report. The analyst increased estimates to reflect faster premium and net investment income growth, bigger reserve releases and lower expenses.

ShowHide Related Items >><<
RLI RLI Corp.
$108.21 /

+0.615 (+0.57%)

RLI RLI Corp.
$108.21 /

+0.615 (+0.57%)

10/19/21
Fly Intel: Top five analyst upgrades
10/19/21 Keefe Bruyette
RLI Corp. upgraded to Outperform from Market Perform at Keefe Bruyette
09/30/21 RBC Capital
RLI Corp. price target lowered to $110 from $115 at RBC Capital
04/23/21 RBC Capital
RLI Corp. price target raised to $115 from $110 at RBC Capital
RLI RLI Corp.
$108.21 /

+0.615 (+0.57%)

Downgrade
WSFS Financial downgraded to Market Perform from Outperform at Keefe Bruyette » 19:23
10/24/21
10/24
19:23
10/24/21
19:23
WSFS

WSFS Financial

$55.60 /

+0.13 (+0.23%)

Keefe Bruyette analyst…

Keefe Bruyette analyst Michael Perito downgraded WSFS Financial to Market Perform from Outperform with an unchanged price target of $56. Following the 29% rally since the Q2 earnings report, WSFS's current valuation "looks pretty fair" pending greater clarity around its net loan growth and "sustainable" return on equity, Perito tells investors in a research note. As such, the analyst sees limited upside in the shares.

ShowHide Related Items >><<
WSFS WSFS Financial
$55.60 /

+0.13 (+0.23%)

WSFS WSFS Financial
$55.60 /

+0.13 (+0.23%)

08/20/21 Seaport Global
WSFS Financial initiated with a Neutral at Seaport Global
07/30/21 Keefe Bruyette
Bryn Mawr Bank upgraded to Outperform from Market Perform at Keefe Bruyette
07/22/21 Keefe Bruyette
WSFS Financial upgraded to Outperform from Market Perform at Keefe Bruyette
03/12/21 Keefe Bruyette
Bryn Mawr Bank downgraded on pending acquisition at Keefe Bruyette
WSFS WSFS Financial
$55.60 /

+0.13 (+0.23%)

WSFS WSFS Financial
$55.60 /

+0.13 (+0.23%)

Conference/Events
Verizon management to meet virtually with Wolfe Research » 17:40
10/24/21
10/24
17:40
10/24/21
17:40
VZ

Verizon

$52.93 /

-0.46 (-0.86%)

Virtual Meeting to be…

Virtual Meeting to be held on October 29 hosted by Wolfe Research.

ShowHide Related Items >><<
VZ Verizon
$52.93 /

-0.46 (-0.86%)

VZ Verizon
$52.93 /

-0.46 (-0.86%)

10/21/21 Cowen
Verizon price target raised to $71 from $68 at Cowen
10/19/21 Deutsche Bank
Verizon resumed with a Hold at Deutsche Bank
10/13/21 Morgan Stanley
Morgan Stanley says Comcast dropping network a modest near-term negative for MSG
09/20/21 Loop Capital
Verizon initiated with a Hold, $57 target at Loop Capital
VZ Verizon
$52.93 /

-0.46 (-0.86%)

VZ Verizon
$52.93 /

-0.46 (-0.86%)

VZ Verizon
$52.93 /

-0.46 (-0.86%)

VZ Verizon
$52.93 /

-0.46 (-0.86%)

Conference/Events
Raytheon Technologies participates in a conference call with Wolfe Research » 17:38
10/24/21
10/24
17:38
10/24/21
17:38
RTX

Raytheon Technologies

$91.87 /

+0.235 (+0.26%)

Defense Analyst Maugeri…

Defense Analyst Maugeri holds a conference call with President of Raytheon Missiles & Defense, Wesley Kremer on October 28 at 3 pm hosted by Wolfe Research. Webcast Link

ShowHide Related Items >><<
RTX Raytheon Technologies
$91.87 /

+0.235 (+0.26%)

RTX Raytheon Technologies
$91.87 /

+0.235 (+0.26%)

09/21/21 Morgan Stanley
New AUKUS pact could benefit General Dynamics, Raytheon, says Morgan Stanley
08/11/21 Morgan Stanley
Raytheon Technologies price target raised to $110 from $97 at Morgan Stanley
07/29/21
Fly Intel: Top five analyst upgrades
07/29/21 Argus
Raytheon Technologies upgraded to Buy from Hold at Argus
RTX Raytheon Technologies
$91.87 /

+0.235 (+0.26%)

RTX Raytheon Technologies
$91.87 /

+0.235 (+0.26%)

RTX Raytheon Technologies
$91.87 /

+0.235 (+0.26%)

RTX Raytheon Technologies
$91.87 /

+0.235 (+0.26%)

Conference/Events
UBS technology, media, telecom analysts hold analyst/industry conference call » 17:34
10/24/21
10/24
17:34
10/24/21
17:34
CDNS

Cadence Design

$166.91 /

+1.46 (+0.88%)

Telecom, Media &…

Telecom, Media & Technology Analysts provide a recap of Cadence reported earnings on an Analyst/Industry conference call to be held on October 26 at 8 am.

ShowHide Related Items >><<
CDNS Cadence Design
$166.91 /

+1.46 (+0.88%)

CDNS Cadence Design
$166.91 /

+1.46 (+0.88%)

10/21/21 Wells Fargo
Cadence Design price target raised to $175 from $165 at Wells Fargo
10/20/21
Fly Intel: Top five analyst initiations
10/20/21 Needham
Cadence Design initiated with a Buy at Needham
10/19/21 Needham
Cadence Design initiated with a Buy at Needham
CDNS Cadence Design
$166.91 /

+1.46 (+0.88%)

CDNS Cadence Design
$166.91 /

+1.46 (+0.88%)

Recommendations
Ocular Therapeutix price target lowered to $20 from $27 at Piper Sandler » 17:33
10/24/21
10/24
17:33
10/24/21
17:33
OCUL

Ocular Therapeutix

$6.91 /

-3.905 (-36.12%)

Piper Sandler analyst…

Piper Sandler analyst Joseph Catanzaro lowered the firm's price target on Ocular Therapeutix to $20 from $27 and keeps an Overweight rating on the shares. The analyst notes the company announced that OTX-CSI decisively missed the primary endpoint in its Phase II dry eye study. While Catanzaro was optimistic based on some early Phase I data and more so the mechanism of action, OTX-CSI provided no benefit over placebo. The analyst has removed all dry eye revenues he was modeling.

ShowHide Related Items >><<
OCUL Ocular Therapeutix
$6.91 /

-3.905 (-36.12%)

OCUL Ocular Therapeutix
$6.91 /

-3.905 (-36.12%)

10/12/21 H.C. Wainwright
Ocular Therapeutix price target raised to $18 from $17 at H.C. Wainwright
10/11/21 Piper Sandler
AC approval 'an important milestone' for Ocular's pipeline, says Piper Sandler
08/10/21 H.C. Wainwright
Ocular Therapeutix upgraded to Buy from Neutral at H.C. Wainwright
02/12/21 Piper Sandler
Ocular Therapeutix to update on OTX-TKI's Phase I wAMD, says Piper Sandler
OCUL Ocular Therapeutix
$6.91 /

-3.905 (-36.12%)

  • 16
    Dec
OCUL Ocular Therapeutix
$6.91 /

-3.905 (-36.12%)

Conference/Events
UBS consumer goods analyst to hold analyst/industry conference call » 17:32
10/24/21
10/24
17:32
10/24/21
17:32

Consumer Goods Analyst…

Consumer Goods Analyst Sole provides an update on the Vietnam factory shutdowns on an Analyst/Industry conference call to be held on October 26 at 8 am.

Conference/Events
UBS consumer goods/services analysts to hold analyst/industry conference call » 17:24
10/24/21
10/24
17:24
10/24/21
17:24

Consumer Goods and…

Consumer Goods and Consumer Services Analysts discuss the current state of the supply chain on an Analyst/Industry conference call to be held on October 25 at 12 pm.

Conference/Events
PAVmed to host virtual investor meeting » 16:55
10/24/21
10/24
16:55
10/24/21
16:55
PAVM

PAVmed

$5.73 /

-0.44 (-7.13%)

Virtual Investor Meeting…

Virtual Investor Meeting to be held on October 26 at 1 pm. Webcast Link

ShowHide Related Items >><<
PAVM PAVmed
$5.73 /

-0.44 (-7.13%)

PAVM PAVmed
$5.73 /

-0.44 (-7.13%)

03/29/21 Cantor Fitzgerald
PAVmed initiated with an Overweight at Cantor Fitzgerald
02/22/21 Lake Street
PAVmed price target raised to $9 from $5 at Lake Street
11/05/20
Fly Intel: Top five analyst initiations
11/05/20 Ascendiant
Ascendiant starts PAVmed with Buy on carpal tunnel potential
  • 23
    Feb
PAVM PAVmed
$5.73 /

-0.44 (-7.13%)

PAVM PAVmed
$5.73 /

-0.44 (-7.13%)

Hot Stocks
Phathom Pharmaceuticals announces data from Phase 3 PHALCON-HP trial » 16:42
10/24/21
10/24
16:42
10/24/21
16:42
PHAT

Phathom Pharmaceuticals

$29.26 /

-0.38 (-1.28%)

Phathom Pharmaceuticals…

Phathom Pharmaceuticals announced data from the PHALCON-HP Phase 3 study, the largest U.S. registrational trial ever conducted for H. pylori, that will be presented during an oral session at the ACG 2021 Annual Scientific Meeting organized by the American College of Gastroenterology, in Las Vegas, Nevada, Oct. 22-27. PHALCON-HP showed that both vonoprazan in combination with amoxicillin and clarithromycin and vonoprazan in combination with amoxicillin demonstrated superior eradication rates in all patients compared to a current standard of care therapy consisting of the proton pump inhibitor, lansoprazole, in combination with amoxicillin and clarithromycin. In the primary endpoint analyses of the PHALCON-HP study comparing the non-inferiority of vonoprazan-based therapies to lansoprazole triple therapy in patients with H. pylori without strains resistant to antibiotics, eradication rates with vonoprazan triple therapy and vonoprazan dual therapy were 84.7% and 78.5%, respectively, compared to 78.8% for lansoprazole triple therapy. In the secondary endpoint analyses comparing the superiority of vonoprazan-based therapies to lansoprazole triple therapy in all patients, eradication rates with vonoprazan triple therapy and dual therapy were 80.8% and 77.2%, respectively, compared to 68.5% for lansoprazole triple therapy. Both vonoprazan-based regimens were generally well tolerated with a safety profile comparable to lansoprazole-based triple therapy in the trial. Phathom is also presenting results from the Study of Acid-Related Disorders which explored perceptions of disease burden for H. pylori and erosive esophagitis among physicians and patients. Physicians completed an online survey recording treatment goals, preferences, satisfaction, and perceived disease burden. A subset completed chart review data of patients with H. pylori and dyspepsia or erosive esophagitis who had received a PPI as part of their treatment. The same patients completed a survey capturing data on treatment goals, satisfaction, and adherence. In this study, only 29% of physicians strongly agreed that they were satisfied with current H. pylori treatment options and 57% of patients stated they were not completely satisfied. When it came to erosive esophagitis, 84% of patients wanted long-lasting treatment options while only 44% considered their current therapy a long-lasting solution for their disease. The study uncovered many unmet needs from the perspective of both physicians and patients in the treatment of H. pylori and erosive esophagitis suggesting that new treatment options are needed.

ShowHide Related Items >><<
PHAT Phathom Pharmaceuticals
$29.26 /

-0.38 (-1.28%)

PHAT Phathom Pharmaceuticals
$29.26 /

-0.38 (-1.28%)

10/18/21 Guggenheim
Phathom Pharmaceuticals price target raised to $75 from $66 at Guggenheim
05/12/21 Goldman Sachs
Phathom Pharmaceuticals upgraded to Neutral from Sell at Goldman Sachs
02/17/21 BMO Capital
Phathom Pharmaceuticals initiated with an Outperform at BMO Capital
02/02/21 Guggenheim
Phathom Pharmaceuticals initiated with a Buy at Guggenheim
PHAT Phathom Pharmaceuticals
$29.26 /

-0.38 (-1.28%)

  • 17
    Dec
PHAT Phathom Pharmaceuticals
$29.26 /

-0.38 (-1.28%)

Conference/Events
Axcella Health to host virtual research and development day » 16:34
10/24/21
10/24
16:34
10/24/21
16:34
AXLA

Axcella Health

$2.76 /

-0.065 (-2.30%)

Virtual Research and…

Virtual Research and Development Day to be held to be held on October 26 at 10 am. Webcast Link

ShowHide Related Items >><<
AXLA Axcella Health
$2.76 /

-0.065 (-2.30%)

AXLA Axcella Health
$2.76 /

-0.065 (-2.30%)

10/12/21 Noble Capital
Axcella Health initiated with an Outperform at Noble Capital
09/22/21 Goldman Sachs
Axcella Health downgraded to Neutral from Buy at Goldman Sachs
07/30/21 JPMorgan
Axcella downgraded to Underweight on lack of catalysts at JPMorgan
07/30/21 JPMorgan
Axcella Health downgraded to Underweight from Neutral at JPMorgan
AXLA Axcella Health
$2.76 /

-0.065 (-2.30%)

AXLA Axcella Health
$2.76 /

-0.065 (-2.30%)

AXLA Axcella Health
$2.76 /

-0.065 (-2.30%)

Conference/Events
BioVie to hold an investor webinar » 16:28
10/24/21
10/24
16:28
10/24/21
16:28
BIVI

BioVie

$5.57 /

-0.12 (-2.11%)

Management, along with…

Management, along with Drs. Kinney and Herrup, discuss the neuroinflammation and insulin resistance and new treatment approaches for Alzheimer's Disease in an Key Opinion Leader Investor Webinar on October 26 at 1:30 pm. Webcast Link

ShowHide Related Items >><<
BIVI BioVie
$5.57 /

-0.12 (-2.11%)

BIVI BioVie
$5.57 /

-0.12 (-2.11%)

05/25/21 B. Riley
BioVie price target raised to $50 from $47 at B. Riley
01/15/21 B. Riley
B. Riley starts 'largely overlooked' BioVie with Buy, $47 target
01/15/21 B. Riley
BioVie initiated with a Buy at B. Riley Securities
  • 09
    Aug
BIVI BioVie
$5.57 /

-0.12 (-2.11%)

On The Fly
Box Office Battle: 'Dune' wins weekend with strong debut despite HBO Max Play » 16:10
10/24/21
10/24
16:10
10/24/21
16:10
T

AT&T

$25.48 /

-0.27 (-1.05%)

, CMCSA

Comcast

$54.21 /

+0.18 (+0.33%)

, CMCSK

Comcast

$58.00 /

+ (+0.00%)

, SONY

Sony

$113.00 /

+0.69 (+0.61%)

, LGF.A

Lionsgate

$14.67 /

-0.01 (-0.07%)

, LGF.B

Lionsgate

$13.10 /

-0.065 (-0.49%)

, DIS

Disney

$169.42 /

-1.965 (-1.15%)

, VIACA

ViacomCBS

$40.38 /

-0.235 (-0.58%)

, VIAC

ViacomCBS

$37.52 /

-0.26 (-0.69%)

"Box Office Battle" is…

ShowHide Related Items >><<
VIACA ViacomCBS
$40.38 /

-0.235 (-0.58%)

VIAC ViacomCBS
$37.52 /

-0.26 (-0.69%)

T AT&T
$25.48 /

-0.27 (-1.05%)

SONY Sony
$113.00 /

+0.69 (+0.61%)

LGF.B Lionsgate
$13.10 /

-0.065 (-0.49%)

LGF.A Lionsgate
$14.67 /

-0.01 (-0.07%)

DIS Disney
$169.42 /

-1.965 (-1.15%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$54.21 /

+0.18 (+0.33%)

T AT&T
$25.48 /

-0.27 (-1.05%)

10/19/21 Citi
AT&T price target lowered to $30 from $32 at Citi
10/14/21
Fly Intel: Top five analyst upgrades
10/14/21 KeyBanc
AT&T upgraded to Sector Weight from Underweight at KeyBanc
10/14/21 KeyBanc
AT&T upgraded to Sector Weight from Underweight at KeyBanc
CMCSA Comcast
$54.21 /

+0.18 (+0.33%)

10/13/21 Morgan Stanley
Morgan Stanley says Comcast dropping network a modest near-term negative for MSG
10/12/21 Deutsche Bank
Comcast price target lowered to $64 from $68 at Deutsche Bank
10/11/21
Fly Intel: Top five analyst downgrades
10/11/21 Raymond James
Comcast downgraded to Market Perform from Outperform at Raymond James
CMCSK Comcast
$58.00 /

+ (+0.00%)

02/23/21 Credit Suisse
SeaWorld price target raised to $52 from $34 at Credit Suisse
SONY Sony
$113.00 /

+0.69 (+0.61%)

09/27/21 Cowen
Sony initiated with an Outperform at Cowen
09/10/21 Truist
Apple will likely appeal ruling in Epic case, says Truist
07/27/21 Morgan Stanley
Sony upgraded to Overweight at Morgan Stanley on animation business growth
07/27/21 Morgan Stanley
Sony upgraded to Overweight from Equal Weight at Morgan Stanley
LGF.A Lionsgate
$14.67 /

-0.01 (-0.07%)

10/13/21
Fly Intel: Top five analyst initiations
10/13/21 Benchmark
Lionsgate initiated with a Buy at Benchmark
07/22/21 Deutsche Bank
Lionsgate downgraded to Hold from Buy at Deutsche Bank
06/04/21 Barrington
Lionsgate price target raised to $27 from $16 at Barrington
LGF.B Lionsgate
$13.10 /

-0.065 (-0.49%)

06/01/21 Cowen
Lionsgate price target raised to $23 from $20 at Cowen
05/28/21 RBC Capital
Lionsgate price target raised to $17 from $13 at RBC Capital
05/26/21 Truist
Amazon's MGM deal 'a very modest negative' for Netflix/Disney, says Truist
DIS Disney
$169.42 /

-1.965 (-1.15%)

10/18/21
Fly Intel: Top five analyst downgrades
10/18/21 MoffettNathanson
Disney price target lowered to $180 from $185 at MoffettNathanson
10/18/21 Barclays
Barclays downgrades Disney on slowing of streaming growth
10/18/21 Barclays
Disney downgraded to Equal Weight from Overweight at Barclays
VIACA ViacomCBS
$40.38 /

-0.235 (-0.58%)

01/05/21 Gabelli
ViacomCBS named a best idea for 2021 at Gabelli
VIAC ViacomCBS
$37.52 /

-0.26 (-0.69%)

10/15/21 Deutsche Bank
ViacomCBS price target lowered to $44 from $45 at Deutsche Bank
08/18/21
Fly Intel: Top five analyst upgrades
08/18/21 Wells Fargo
ViacomCBS upgraded to Overweight from Equal Weight at Wells Fargo
08/06/21
Fly Intel: Top five analyst upgrades
VIACA ViacomCBS
$40.38 /

-0.235 (-0.58%)

T AT&T
$25.48 /

-0.27 (-1.05%)

SONY Sony
$113.00 /

+0.69 (+0.61%)

LGF.A Lionsgate
$14.67 /

-0.01 (-0.07%)

DIS Disney
$169.42 /

-1.965 (-1.15%)

CMCSA Comcast
$54.21 /

+0.18 (+0.33%)

  • 06
    Apr
  • 29
    Mar
  • 24
    Mar
VIACA ViacomCBS
$40.38 /

-0.235 (-0.58%)

VIAC ViacomCBS
$37.52 /

-0.26 (-0.69%)

T AT&T
$25.48 /

-0.27 (-1.05%)

SONY Sony
$113.00 /

+0.69 (+0.61%)

LGF.A Lionsgate
$14.67 /

-0.01 (-0.07%)

DIS Disney
$169.42 /

-1.965 (-1.15%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$54.21 /

+0.18 (+0.33%)

T AT&T
$25.48 /

-0.27 (-1.05%)

SONY Sony
$113.00 /

+0.69 (+0.61%)

LGF.A Lionsgate
$14.67 /

-0.01 (-0.07%)

DIS Disney
$169.42 /

-1.965 (-1.15%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$54.21 /

+0.18 (+0.33%)

VIAC ViacomCBS
$37.52 /

-0.26 (-0.69%)

T AT&T
$25.48 /

-0.27 (-1.05%)

SONY Sony
$113.00 /

+0.69 (+0.61%)

DIS Disney
$169.42 /

-1.965 (-1.15%)

CMCSA Comcast
$54.21 /

+0.18 (+0.33%)

Conference/Events
Aslan Pharmaceuticals to hold an investor webinar » 16:10
10/24/21
10/24
16:10
10/24/21
16:10
ASLN

Aslan Pharmaceuticals

$1.47 /

-0.12 (-7.55%)

Management discusses the…

Management discusses the recently announced, positive topline data from the Company's randomized, double-blind, placebo-controlled, 8-week, multiple-ascending-dose (MAD) Phase 1 study of ASLAN004 for treatment of moderate-to-severe atopic dermatitis (AD) in an Investor Webinar to be held on October 25 at 10 am. Webcast Link

ShowHide Related Items >><<
ASLN Aslan Pharmaceuticals
$1.47 /

-0.12 (-7.55%)

ASLN Aslan Pharmaceuticals
$1.47 /

-0.12 (-7.55%)

09/27/21 Piper Sandler
Piper buyers on Aslan weakness, thinks ASLAN-004 can be competitive
07/09/21 Jefferies
Aslan Pharmaceuticals initiated with a Buy at Jefferies
05/11/21 Piper Sandler
Aslan Pharmaceuticals price target lowered to $8 from $9 at Piper Sandler
03/17/21 H.C. Wainwright
Aslan Pharmaceuticals price target raised to $8 from $5 at H.C. Wainwright
ASLN Aslan Pharmaceuticals
$1.47 /

-0.12 (-7.55%)

  • 03
    Mar
ASLN Aslan Pharmaceuticals
$1.47 /

-0.12 (-7.55%)

ASLN Aslan Pharmaceuticals
$1.47 /

-0.12 (-7.55%)

Periodicals
Tesla raises price of Model X, Model S variants by $5,000, Reuters says » 15:39
10/24/21
10/24
15:39
10/24/21
15:39
TSLA

Tesla

$909.51 /

+15.82 (+1.77%)

Tesla has increased the…

Tesla has increased the price of its Model X Long Range and Model S Long Range variants by $5,000, according to Reuters. The Model X Long Range and Model S Long Range now sell for $104,990 and $94,990, respectively. Prices for the Model Y Long Range and Model 3 Standard Range Plus rose by $2,000, to $56,990 and $43,990, respectively, the publication notes. Reference Link

ShowHide Related Items >><<
TSLA Tesla
$909.51 /

+15.82 (+1.77%)

TSLA Tesla
$909.51 /

+15.82 (+1.77%)

10/24/21 Morgan Stanley
Morgan Stanley sees several reasons why Tesla's Q3 'is bearish' for Autos
10/21/21 RBC Capital
Tesla price target raised to $800 from $755 at RBC Capital
10/21/21 Credit Suisse
Tesla price target raised to $830 from $800 at Credit Suisse
10/21/21 Wedbush
Tesla price target raised to $1,100 from $1,000 at Wedbush
TSLA Tesla
$909.51 /

+15.82 (+1.77%)

TSLA Tesla
$909.51 /

+15.82 (+1.77%)

TSLA Tesla
$909.51 /

+15.82 (+1.77%)

TSLA Tesla
$909.51 /

+15.82 (+1.77%)

On The Fly
Week in SPAC News: Digital World soars after Trump Media deal » 15:36
10/24/21
10/24
15:36
10/24/21
15:36
TWTR

Twitter

$62.24 /

-3.16 (-4.83%)

, FB

Facebook

$324.68 /

-17.41 (-5.09%)

, DWAC

Digital World Acquisition

$94.00 /

+48.06 (+104.61%)

, WMT

Walmart

$148.34 /

+1.485 (+1.01%)

, SVFC

SVF Investment Corp. 3

$9.89 /

-0.035 (-0.35%)

, BOWX

BowX Acquisition

$10.39 /

+ (+0.00%)

, WE

WeWork

$13.00 /

+1.245 (+10.60%)

, DCRN

Decarbonization Plus Acquisition Corp. II

$9.94 /

+0.025 (+0.25%)

, NHIC

NewHold Investment Corp. II

/

+

, GTAC

Global Technology Acquisition I

/

+

, THAC

Thrive Acquisition

/

+

, XFIN

ExcelFin Acquisition

/

+

, GOGN

GoGreen Investments

/

+

, NCAC

Newcourt Acquisition

/

+

, ESAC

Esgen Acquisition

/

+

, WWAC

Worldwide Webb Acquisition

/

+

, AXH

Industrial Human Capital

/

+

, ACAQ

Athena Consumer Acquisition

/

+

, FEXD

Fintech Ecosystem Development

/

+

, BMAQ

Blockchain Moon Acquisition

/

+

, SMAP

SportsMap Tech Acquisition

/

+

In SPAC news this week,…

ShowHide Related Items >><<
WMT Walmart
$148.34 /

+1.485 (+1.01%)

WE WeWork
$13.00 /

+1.245 (+10.60%)

TWTR Twitter
$62.24 /

-3.16 (-4.83%)

NHIC NewHold Investment Corp. II
/

+

FB Facebook
$324.68 /

-17.41 (-5.09%)

DWAC Digital World Acquisition
$94.00 /

+48.06 (+104.61%)

DCRN Decarbonization Plus Acquisition Corp. II
$9.94 /

+0.025 (+0.25%)

BOWX BowX Acquisition
$10.39 /

+ (+0.00%)

TWTR Twitter
$62.24 /

-3.16 (-4.83%)

10/24/21 BofA
Twitter price target lowered to $82 from $90 at BofA
10/22/21 Piper Sandler
Snap results raise uncertainty for digital advertising, says Piper Sandler
10/18/21 Wedbush
Wedbush continues to favor Google, Snap headed into quarterly results
10/07/21 Oppenheimer
AppLovin price target raised to $95 from $75 at Oppenheimer
FB Facebook
$324.68 /

-17.41 (-5.09%)

10/18/21 Credit Suisse
Facebook algorithm, service outages grab investor attention, says Credit Suisse
10/15/21 Evercore ISI
Facebook added to 'Tactical Underperform List' at Evercore ISI
DWAC Digital World Acquisition
$94.00 /

+48.06 (+104.61%)

WMT Walmart
$148.34 /

+1.485 (+1.01%)

10/19/21
Fly Intel: Top five analyst upgrades
10/18/21 Goldman Sachs
Walmart upgraded to Conviction Buy from Buy at Goldman Sachs
10/06/21 Morgan Stanley
Affirm relationship with Target not new, says Morgan Stanley
09/29/21 Piper Sandler
Piper ups Impinj target to $75 after finding RFID in Walmart
SVFC SVF Investment Corp. 3
$9.89 /

-0.035 (-0.35%)

BOWX BowX Acquisition
$10.39 /

+ (+0.00%)

WE WeWork
$13.00 /

+1.245 (+10.60%)

DCRN Decarbonization Plus Acquisition Corp. II
$9.94 /

+0.025 (+0.25%)

10/21/21 Roth Capital
Decarbonization Plus Acquisition Corp. II initiated with a Buy at Roth Capital
10/19/21 DA Davidson
Decarbonization Plus Acquisition Corp. II initiated with a Buy at DA Davidson
10/05/21 Fox Advisors
Decarbonization Plus Acquisition Corp. II initiated with an Overweight at Fox Advisors
NHIC NewHold Investment Corp. II
/

+

07/08/21
NewHold Investment Corp. participates in a conference call hosted by Northland
06/29/21 Northland
NewHold Investment Corp. initiated with an Outperform at Northland
GTAC Global Technology Acquisition I
/

+

THAC Thrive Acquisition
/

+

XFIN ExcelFin Acquisition
/

+

GOGN GoGreen Investments
/

+

NCAC Newcourt Acquisition
/

+

ESAC Esgen Acquisition
/

+

WWAC Worldwide Webb Acquisition
/

+

AXH Industrial Human Capital
/

+

ACAQ Athena Consumer Acquisition
/

+

FEXD Fintech Ecosystem Development
/

+

BMAQ Blockchain Moon Acquisition
/

+

SMAP SportsMap Tech Acquisition
/

+

WMT Walmart
$148.34 /

+1.485 (+1.01%)

TWTR Twitter
$62.24 /

-3.16 (-4.83%)

FB Facebook
$324.68 /

-17.41 (-5.09%)

WMT Walmart
$148.34 /

+1.485 (+1.01%)

TWTR Twitter
$62.24 /

-3.16 (-4.83%)

FB Facebook
$324.68 /

-17.41 (-5.09%)

WMT Walmart
$148.34 /

+1.485 (+1.01%)

TWTR Twitter
$62.24 /

-3.16 (-4.83%)

SVFC SVF Investment Corp. 3
$9.89 /

-0.035 (-0.35%)

FB Facebook
$324.68 /

-17.41 (-5.09%)

DWAC Digital World Acquisition
$94.00 /

+48.06 (+104.61%)

WMT Walmart
$148.34 /

+1.485 (+1.01%)

WE WeWork
$13.00 /

+1.245 (+10.60%)

TWTR Twitter
$62.24 /

-3.16 (-4.83%)

NHIC NewHold Investment Corp. II
/

+

FB Facebook
$324.68 /

-17.41 (-5.09%)

BOWX BowX Acquisition
$10.39 /

+ (+0.00%)

Recommendations
Snap price target lowered to $67 from $80 at BofA » 09:26
10/24/21
10/24
09:26
10/24/21
09:26
SNAP

Snap

$55.14 /

-20.05 (-26.67%)

BofA analyst Justin Post…

BofA analyst Justin Post lowered the firm's price target on Snap to $67 from $80 and keeps a Neutral rating on the shares following quarterly results. The analyst said in a research note on Friday that the outlook suggests both ad measurement and supply chain pressure on Q4 direct response ad spend, a negative for the Online media sector.

ShowHide Related Items >><<
SNAP Snap
$55.14 /

-20.05 (-26.67%)

SNAP Snap
$55.14 /

-20.05 (-26.67%)

10/22/21 RBC Capital
Snap price target lowered to $70 from $88 at RBC Capital
10/22/21 Truist
Snap price target lowered to $75 from $100 at Truist
10/22/21 Jefferies
Snap price target lowered to $76 from $90 at Jefferies
10/22/21 KeyBanc
Snap price target lowered to $85 from $90 at KeyBanc
SNAP Snap
$55.14 /

-20.05 (-26.67%)

SNAP Snap
$55.14 /

-20.05 (-26.67%)

SNAP Snap
$55.14 /

-20.05 (-26.67%)

SNAP Snap
$55.14 /

-20.05 (-26.67%)

Recommendations
Beyond Meat price target lowered to $80 from $95 at BofA » 09:24
10/24/21
10/24
09:24
10/24/21
09:24
BYND

Beyond Meat

$95.78 /

-12.66 (-11.67%)

BofA analyst Bryan…

BofA analyst Bryan Spillane lowered the firm's price target on Beyond Meat to $80 from $95 and keeps an Underperform rating on the shares. The analyst pointed out on a research note on Friday that the company has issued a press release updating its Q3 sales outlook to $106M versus prior outlook of $120M-$140M.

ShowHide Related Items >><<
BYND Beyond Meat
$95.78 /

-12.66 (-11.67%)

BYND Beyond Meat
$95.78 /

-12.66 (-11.67%)

10/22/21 Goldman Sachs
Beyond Meat price target lowered to $85 from $99 at Goldman Sachs
10/05/21 Piper Sandler
Piper teen survey shows clothing outranked food for first time since 2014
09/16/21
Fly Intel: Top five analyst downgrades
09/16/21 Piper Sandler
Piper Sandler downgrades Beyond Meat to sell, says estimates too high
BYND Beyond Meat
$95.78 /

-12.66 (-11.67%)

BYND Beyond Meat
$95.78 /

-12.66 (-11.67%)

BYND Beyond Meat
$95.78 /

-12.66 (-11.67%)

BYND Beyond Meat
$95.78 /

-12.66 (-11.67%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.